Journal of Molecular Biology
Volume 326, Issue 2, 14 February 2003, Pages 381-396
Journal home page for Journal of Molecular Biology

Role of Residues in the Tryptophan Repeat Motif for HIV-1 Reverse Transcriptase Dimerization

https://doi.org/10.1016/S0022-2836(02)01433-XGet rights and content

Abstract

The tryptophan repeat motif of the human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) is comprised of a cluster of six tryptophan residues at codons 398, 401, 402, 406, 410 and 414 that are highly conserved amongst primate lentiviral RTs. To determine the contributions of each of these residues for HIV-1 RT dimerization, we introduced changes into cloned DNA and tested the mutant subunits for their capacity to mediate heterodimerization in the yeast two-hybrid system. Changes of residue 401 to either leucine or alanine (but not phenylalanine) and residue 414 to leucine resulted in major reductions in β-galactosidase activity produced from the reporter gene as compared to yeast expressing wild-type p66 bait and p51 prey fusions. Subunit selective mutagenesis revealed that the effect of these mutations was mediated mainly through the p66 subunit. Introduction of tryptophan mutants into the bacterial expression vector pRT6H/NB-PROT showed that RTs containing W401A or W401L substitutions (but not W401F) and W414L were defective for dimerization in vitro. Consistent with their dimerization defect, the W401A, W401L and W414L mutants were devoid of RT activity. Using the yeast two-hybrid system, we identified several second-site suppressors in p66 that restored interaction of the p66W401A bait to the p51W401A prey. The suppressors (T409I, D110G, V372A and I393M) also restored heterodimerization of bacterially expressed W401A subunits. When introduced into the W401A mutant, T409I was able to restore RT activity to 50% of the wild-type level. Examination of the RT structures revealed that K331 in p51 makes multiple hydrogen bond contacts with residues in the p66 loop spanned by W401 and W414. Consistent with this observation, the K331A RT mutant was dimerization-defective. We conclude that mutations at codons 401 and 414 in p66 impair dimerization by altering the proper positioning of structural elements in between these residues that make important contacts with p51.

Introduction

The human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) is required for the conversion of genomic RNA into double-stranded proviral DNA, catalyzed by the RNA- and DNA-dependent polymerase and ribonuclease H (RNase H) activities of the enzyme. The HIV-1 RT is an asymmetric dimer formed by the association of polypeptides p66 and p51, which are cleaved from a large Pr160GagPol precursor by the viral protease (PR) during virion assembly. p51 contains the same N-terminal sequence as p66, but lacks the C-terminal RNase H domain.1

The structure of HIV-1 RT has been elucidated by X-ray crystallography in several contexts, including the unliganded enzyme,2., 3. complexed to non-nucleoside RT inhibitors (NNRTIs),4., 5. or complexed with double-stranded DNA either with6 or without deoxynucleoside triphosphate.7., 8. Such analyses have shown that p66 can be divided structurally into the polymerase and RNase H domains, with the polymerase domain further divided into the fingers, palm, thumb and connections subdomains.8 p66 has a nucleic acid-binding cleft and a DNA polymerase active site. While p51 has the same polymerase subdomains as p66, the relative orientations of the individual subdomains differ markedly in p51. These structural analyses reveal that there are three major contacts between the p66 and p51 subunits, with most of the interaction surfaces being largely hydrophobic.9., 10.

The RT heterodimer represents the biologically relevant form of the enzyme; monomeric subunits are reported to be devoid of both polymerase and RNase H activities.11., 12. Dimerization of the p66 and p51 subunits in vitro can be achieved, though under very non-physiological conditions, and appears to occur by a two-step process.13 The first step involves a concentration-dependent reaction resulting in a dimer intermediate that can bind template/primer but lacks polymerase activity. The second step involves a slow isomerisation reaction that ultimately results in an active enzyme. Hence, formation of an active enzyme requires subunit interaction and conformational changes. The absolute requirement for dimerization of the two RT subunits to generate a fully active enzyme makes dimerization an attractive drug target. Understanding the mechanism and structural basis of dimerization is necessary for the development of strategies to interfere with this process.

The tryptophan repeat motif represents an extraordinary cluster of six tryptophan residues, five of which are separated from each other by three amino acid residues (Figure 1, Figure 6).14 The tryptophan repeat motif is found in the connection subdomain of both HIV-1 RT subunits from codons 398–414. This hydrophobic cluster is highly conserved amongst primate lentiviral reverse transcriptases.14 Interestingly, it is not present in other lentiviral RTs that are known to form heterodimers, including feline immunodeficiency virus (FIV) RT. The tryptophan repeat motif is absent from RTs from other retrovirus families, including the heterodimeric avian sarcoma leukosis virus (ASLV) and Moloney murine leukemia virus (MoMLV), which may dimerize when presented with a template.15

Previous studies suggest that the tryptophan repeat motif is important for RT dimerization. Elucidation of the kinetics of association of p66 and p51 RT subunits implicates tryptophan residues as being involved in the initial interaction of the two monomers.16 Subsequent studies have shown that a 19-mer peptide corresponding to residues 389–407 of the HIV-1 RT tryptophan repeat motif can inhibit the association between p66 and p51 when present at micromolar concentrations, but cannot induce heterodimer dissociation.17 In contrast, a peptide representing residues 403–415 had little effect on in vitro RT dimerization.17 These data suggest that the 19-mer (389–407) peptide interferes with the first step in monomer association. Moreover, a peptide corresponding to residues 395–404 could block RT dimerization in vitro and could abolish the production of viral particles in infected cells.18 The activity of this peptide was further enhanced by conjugation to carrier peptide.18

Dimerization is associated with loss of accessibility of individual residues at the HIV-1 RT dimer interface.19 Recent studies on the characterization of protein–protein interactions suggest that the free energy of binding is often distributed unevenly across the interface. These “hot spots” of binding energy tend to involve a subset of interface residues and include W, R or Y and, to a lesser extent P, L, D and K, which are occluded from the bulk solvent by energetically less important residues.20 Many of the tryptophan residues in the tryptophan repeat motif, including W402, W406 and W410 in the p66 subunit and W401 in the p51 subunit, are predicted to be buried at the dimer interface and may represent hot spots for binding.19

To facilitate studies of RT dimerization, we have developed a genetic assay based on the yeast two-hybrid (Y2H) system,21 which detects the specific interaction between the p66 and p51 RT subunits and recapitulates the effects of mutations that abrogate RT dimerization.22 The study of RT heterodimerization either in the Y2H assay or in cell-free assays does not necessarily reflect the actual process in HIV-infected cells. The HIV-1 RT is normally expressed as part of the Pr160GagPol precursor,23 and it is unclear how the RT heterodimer is formed from the Pol portion of the polyprotein. Studies have led to the hypothesis that the immediate precursor to the RT heterodimer is the p66 homodimer.10., 24. In spite of these uncertainties, examining the association of p66 and p51 subunits in yeast has provided insights into the RT dimerization process.13., 22., 25.

In one version of our Y2H system, the p66 RT subunit is fused to the C terminus of the LexA DNA-binding domain to generate the bait fusion, while the p51 RT subunit is fused to the C terminus of the Gal4 activation domain (Gal4AD), which is referred to as the prey fusion.22., 25. Specific interaction between the bait and prey results in the transactivation of the Lac Z reporter gene in yeast. Therefore, the interaction can be quantified accurately by measuring β-galactosidase (β-gal) activity in the yeast reporter strain. One of the advantages of the Y2H system is that we can select and screen for suppressor mutations that restore dimerization to an assembly-defective mutant.22 These studies can provide insight into the structural basis of mutations that interfere with RT dimerization and shed light on amino acid contacts that are energetically important for subunit association. In this study, we performed a systematic mutagenesis of each of the tryptophan residues in the tryptophan repeat motif to assess their individual affects on RT dimerization. We identified suppressors that restore dimerization to an assembly-defective mutant and identified a region in p66 that appears to make important contacts with p51.

Section snippets

Effect of mutations in the tryptophan repeat motif on RT heterodimerization in the Y2H system

The tryptophan repeat motif is present in the connection subdomain of both subunits of the HIV-1 RT and consists of six tryptophan residues at codons 398, 401, 402, 406, 410 and 414 that are highly conserved amongst primate lentiviral RTs (Figure 1).14 Furthermore, a highly conserved tyrosine residue is located at codon 405 (Figure 1). To determine the contribution of each of these conserved residues to HIV-1 RT dimerization we mutagenized the individual tryptophan and tyrosine residues to

Discussion

In this study, we have shown using the Y2H assay that mutagenesis of W401 and W414 in the p66 subunit impairs dimerization with p51 significantly, whereas mutagenesis of other tryptophan residues and Y405 to leucine does not result in detectable effects on RT dimerization. These data were confirmed by studies on RT expressed in bacteria. While W401 and W414 in the p66 subunit are near the heterodimer interface, they do not appear to make direct contacts with amino acid residues in p51,

Bacterial and yeast strains

Saccharomyces cerevisiae strain CTY10-5d (MATa ade2 trp1-901 leu2-3,112 his3-200 gal4gal80 URA3∷lexA-lacZ) contains an integrated GAL1-lacZ gene with the lexA operator (a gift from Stanley Fields, State University of New York, Stony Brook). Escherichia coli mutator strain XL1-Red (Stratagene, La Jolla, CA) was used for random mutagenesis whereas XL1-Blue (Stratagene) was used to amplify the mutated library and for cloning into expression vectors pQE-70 (Qiagen, Chatsworth, CA) and

Acknowledgements

We thank Drs Wayne A. Hendrickson and Marianna Orlova for helpful discussions, Dr Vinayaka Prasad for providing the pRT6H/NB-PROT construct, Drs Clyde A. Hutchison III, John Wrobel and Michael Conrad for providing pE66MK331A, and Dr Dag Helland for providing RT monoclonal antibodies. G.T. was supported, in part, by C. J. Martin Fellowship 977375 awarded by the National Health and Medical Research Council of Australia. S.P.G. is an Investigator of the Howard Hughes Medical Institute. H.-E.G.A.

References (48)

  • E.G. Argyris et al.

    The connection domain is implicated in metalloporphyrin binding and inhibition of HIV reverse transcriptase

    J. Biol. Chem.

    (1999)
  • M. Amacker et al.

    Chimeric HIV-1 and feline immunodeficiency virus reverse transcriptases: critical role of the p51 subunit in the structural integrity of heterodimeric lentiviral DNA polymerases

    J. Mol. Biol.

    (1998)
  • H.E. Huber et al.

    Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching

    J. Biol. Chem.

    (1989)
  • J. Luban et al.

    Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B

    Cell

    (1993)
  • T.A. Kunkel et al.

    Rapid and efficient site-specific mutagenesis without phenotypic selection

    Methods Enzymol.

    (1987)
  • P.S. Jacques et al.

    Modulation of HIV-1 reverse transcriptase function in selectively deleted p66/p51 heterodimers

    J. Biol. Chem.

    (1994)
  • A. Telesnitsky et al.

    Assays for retroviral reverse transcriptase

    Methods Enzymol.

    (1995)
  • F. di Marzo Veronese et al.

    Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV

    Science

    (1986)
  • D.W. Rodgers et al.

    The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1

    Proc. Natl Acad. Sci. USA

    (1995)
  • J. Ren et al.

    High resolution structures of HIV-1 RT from four RT-inhibitor complexes

    Nature Struct. Biol.

    (1995)
  • J. Ding et al.

    Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors

    Nature Struct. Biol.

    (1995)
  • H. Huang et al.

    Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance

    Science

    (1998)
  • A. Jacobo-Molina et al.

    Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA

    Proc. Natl Acad. Sci. USA

    (1993)
  • L.A. Kohlsteaedt et al.

    Crystal structure of 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor

    Science

    (1992)
  • Cited by (62)

    • The CARD8 inflammasome in HIV infection

      2023, Advances in Immunology
    • Retroviral RNase H: Structure, mechanism, and inhibition

      2021, Enzymes
      Citation Excerpt :

      However, how this high-affinity (KD of the heterodimer is 1–300 nM [109,119]) and large interface (~ 3000 Å2 [120,121]) can be overcome by a small molecular inhibitor is not clear. Nevertheless, this approach is supported by the observation that a single substitution mutation in RT significantly lowers the dimerization affinity, suggesting that it is possible to reduce dimerization by targeting key contacts in the interface [111,122–125]. The proposed target sites for dimerization inhibitor binding have been summarized by Tachedjian and colleagues [126], and among these, recent studies have targeted two: the β7-β8 loop and a Trp-rich region [115–117].

    • Mutations in the HIV-1 reverse transcriptase tryptophan repeat motif affect virion maturation and Gag-Pol packaging

      2012, Virology
      Citation Excerpt :

      This reconfirms the critical role of the RT Trp repeat motif in HIV-1 replication. Past results from yeast two-hybrid screens for RT dimerization and in vitro binding assays indicate mutations at W401 and W414, both in the context of p66RT subunit abrogate RT heterodimerization (Tachedjian et al., 2003). In addition, infectious virion assay results show that residues W398, W401, W402, Y405, W406 and W414 mediate RT subunit interactions (Mulky et al., 2005).

    View all citing articles on Scopus

    Present addresses: G. Tachedjian, AIDS Molecular Biology Unit, Macfarlane Burnet Institute for Medical Research and Public Health, Commercial Road, Melbourne, Victoria, Australia 3004. GPO Box 2284; H.-E. G. Aronson, Columbia Genome Center, Russ Berrie Medical Science Pavilion, 1150 St. Nicholas Avenue, New York, NY 10032, USA; J. M. McCoy, Biogen Inc. 14 Cambridge Center, Cambridge, MA 02142, USA.

    View full text